Correlation Between Anebulo Pharmaceuticals and PaxMedica, Common

Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and PaxMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and PaxMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anebulo Pharmaceuticals and PaxMedica, Common Stock, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and PaxMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of PaxMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and PaxMedica, Common.

Diversification Opportunities for Anebulo Pharmaceuticals and PaxMedica, Common

0.74

Correlation Coefficient

Anebulo Pharmaceuticals  PaxMedica, Common

Poor diversification

The 3 months correlation between Anebulo and PaxMedica, is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and PaxMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PaxMedica, Common Stock and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with PaxMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PaxMedica, Common Stock has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and PaxMedica, Common go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and PaxMedica, Common

If you would invest  177.00  in Anebulo Pharmaceuticals on September 11, 2024 and sell it today you would lose (21.00) from holding Anebulo Pharmaceuticals or give up 11.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	1.59%
Values	Daily Returns

Anebulo Pharmaceuticals  vs.  PaxMedica, Common Stock

Anebulo Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Anebulo Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile technical and fundamental indicators, Anebulo Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

PaxMedica, Common Stock

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PaxMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, PaxMedica, Common is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Anebulo Pharmaceuticals and PaxMedica, Common

The main advantage of trading using opposite Anebulo Pharmaceuticals and PaxMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, PaxMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PaxMedica, Common will offset losses from the drop in PaxMedica, Common's long position.

The idea behind Anebulo Pharmaceuticals and PaxMedica, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.